(19)
(11) EP 1 556 353 A1

(12)

(43) Date of publication:
27.07.2005 Bulletin 2005/30

(21) Application number: 03787960.8

(22) Date of filing: 04.08.2003
(51) International Patent Classification (IPC)7C07D 213/38, C07D 213/70, A61K 31/44, A61P 15/00, A61P 25/00
(86) International application number:
PCT/IB2003/003510
(87) International publication number:
WO 2004/016593 (26.02.2004 Gazette 2004/09)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 16.08.2002 GB 0219154

(71) Applicants:
  • Pfizer Limited
    Sandwich,Kent CT13 9NJ (GB)

    GB 
  • PFIZER INC.
    New York, N.Y. 10017 (US)

    AT BE BG CH CY CZ DE DK EE ES FI FR GR HU IE IT LU MC NL PT 

(72) Inventors:
  • ANDREWS, M.D.Pfizer Global Res. and Development
    Kent CT13 9NJ (GB)
  • HEPWORTH, D.Pfizer Global Res. and Development
    Kent CT13 9NJ (GB)
  • MIDDLETON, D.S.Pfizer Global Res.and Development
    Kent CT13 9NJ (GB)

(74) Representative: Rutt, Jason Edward 
Pfizer LimitedEuropean Patents Department,Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) DIARYL COMPOUNDS AS MONOAMINE REUPTAKE INHIBITORS